NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Management of Patients With COVID-19

Summary of Guidance for Minimizing the Impact of COVID-19 on

Frontiers Drugs for the prevention and treatment of COVID-19 and

Global interim guidance on coronavirus disease 2019 (COVID‐19

Messages from the COVID-19 Response Task Force

Management of Patients With COVID-19

Comparative therapeutic efficacy of remdesivir and combination

Clinical outcomes of hospitalized COVID-19 patients treated with

Critical study of Gilead drug shows coronavirus patients

Favipiravir, camostat, and ciclesonide combination therapy in

SARS-CoV-2 Infection and COVID-19 During Pregnancy: A